One Must-Own Dividend Stock with a 46-Year Dividend Growth Streak

My Top Dividend Stocks for 2023 [FREE]

Sponsored

Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century! I think it's a crying shame folks don't know how powerful dividends are. That's why, today, I'm giving you my Ultimate Dividend Package – completely free of charge. (Seriously… no credit card required.) You'll get my top dividend picks and my favorite strategies… so you can collect massive income while you enjoy life! Inside, you'll discover:

  • How you can lock in an ULTRA-SAFE 9% yield…
  • My top three “Extreme Dividend” stocks, which could supercharge your dividend gains.
  • My No. 1 dividend stock for a LIFETIME of income.
  • How you can make money even if a stock goes DOWN… without options, shorting or anything fancy.
  • How you can turn a small dividend yield of even 2% into a 5%… 10%… even a 20% yield on your initial investment… with one little trick!

Click Here for Your Free Ultimate Dividend Package. Don't miss your chance to grab this incredibly powerful package for free! P.S. When I say FREE, I mean it. There is no catch, you get my entire Ultimate Dividend Package… including my #1 dividend stock…. Free of charge.


Medtronic plc (NYSE:MDT) is a leading American medical device company with legal headquarters in Ireland. The company operates across various healthcare sectors, offering a broad range of products and services designed to improve patient outcomes and enhance quality of life.

Financial Performance

In fiscal Q1 2023, Medtronic reported revenue of $8.5 billion, marking a 5.6% increase from the same period last year. For FY23, the company generated $6.03 billion in operating cash flow, with free cash flow for the period standing at $4.5 billion. Medtronic has also demonstrated its commitment to returning value to shareholders, with $4 billion returned in dividends and share repurchases in FY23.

Dividend Growth

Medtronic has a strong track record as a dividend stock. Over the past five years, the company has increased its dividends by 38%. This impressive growth is part of a 46-year streak of consistent dividend growth, a testament to the company's financial stability and commitment to shareholder returns. As of July 12, the stock's dividend yield was 3.15%, making it an attractive option for income-focused investors.

Institutional Ownership

At the end of Q1 2023, 52 hedge funds reported holding stakes in Medtronic, collectively valued at over $1.64 billion. First Eagle Investment Management was the leading stakeholder, with over 5.4 million shares. This level of institutional ownership often indicates confidence in the company's long-term prospects.

Market Position and Future Outlook

Medtronic is the world's largest device manufacturer, holding the number one or number two market share in most of its product segments. The company's business is heavily weighted towards complex in-patient procedures, which are typically quite profitable.

The industry dynamics are favorable, with an aging global population and the growth of improved healthcare in emerging markets. Most of Medtronic's segments are highly concentrated, with just 2-3 players splitting each segment's market share. This affords the key participants significant economies of scale and pricing power.

Despite facing temporary headwinds such as a strong dollar, inflation, a delayed recovery in surgical volumes from the coronavirus pandemic, and supply chain issues, Medtronic is well-positioned to overcome these challenges. Once these issues are resolved, the company's growth and margin expansion plans should materialize.

Conclusion

Given its strong financial performance, consistent dividend growth, and promising market position, Medtronic plc (NYSE:MDT) presents a compelling investment opportunity for those seeking a reliable dividend stock to buy and hold for the long term. As always, investors are encouraged to conduct their own thorough research before making investment decisions.


A 10,000% Dividend?!?

Sponsored

Have you seen this strange oil investment?

It's NOT a stock, bond, or private company…

It has NO age requirements…

You do NOT need to be accredited to participate…

And you can get in for as little as $25.

Yet this secret is so powerful that one man used it to build a $100,000 income stream from just $1,000.

And he was collecting this income even 50 years later!

That's like earning a 10,000% dividend year after year!

In short…

This is easily the #1 Oil Play for 2023 and beyond.

My short presentation reveals everything:

Get the Details of This Special Income Play Here

$2 EV Stock No One's Talking About

This company is a sneaky EV play that no one’s talking about. They’re producing an odd variation on the traditional EV that has consumers raving.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

$30 Stock Freaking Out Billionaires

This stock is an industry leader in a robotics technology that is freaking out billionaires (trading for just $30).

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

The Best TaaS Stock Right Now

This company is set to corner the market in a self-driving technology that  could fundamentally change our entire society – much like the internet did.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

Up to 20,000 IPOs All in One Day

A radical $2.1 quadrillion shift is coming to the financial markets.

Some are calling it G.T.E. and Mark Cuban, Elon Musk, Richard Branson, and even banks like J.P. Morgan are invested in the tech behind it.

Just $25 could get you in alongside these billionaires. 

Enter your email address to receive the video that reveals it all.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works

53-cent Biotech Stock with $2 Price Target

Steve Cohen, the billionaire stock picker known for running one of the most successful hedge funds ever, has poured millions into the first stock, and it’s trading for only 53 cents.

Enter your email address to receive this company’s name and ticker symbol for free.



By submitting your email address, you give Stock Market Junkie permission to deliver the report or research you’re requesting to your email inbox. As a bonus, you will also get a free subscription to one of our carefully selected marketing partners. You can unsubscribe at any time. To review our privacy policy, click here: Privacy Policy | How it Works